Alpha Tau Medical (DRTS) Net Income towards Common Stockholders Growth (3y) (2024 - 2026)
Alpha Tau Medical (DRTS) Net Income towards Common Stockholders Growth (3y) (2024 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-10.84% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
26.38% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-46.86% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
34.98% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Alpha Tau Medical |
2,386.80 |
-76.42 Mn |
- |
41.24% |
| Date | Value |
|---|
| Mar 31, 2026 |
41.24% |
| Dec 31, 2025 |
53.27% |
| Sep 30, 2025 |
65.00% |
| Jun 30, 2025 |
71.28% |
| Mar 31, 2025 |
-30.90% |
| Dec 31, 2024 |
35.48% |
| Sep 30, 2024 |
12.93% |
| Jun 30, 2024 |
1.93% |
| Mar 31, 2024 |
-11.95% |
